CA
FMS icon

CoreCap Advisors’s Fresenius Medical Care FMS Stock Holding History

CoreCap Advisors’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-110
Closed -$2.74K – 2929
2025
Q1 		$2.74K Buy
+110
New +$2.62K ﹤0.01% 2271

Other funds holding FMS

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CoreCap Advisors's FMS Position: Q2 2025 in Review

CoreCap Advisors sold out of Fresenius Medical Care (FMS) in Q2 2025, closing a stake of 110 shares — an estimated $2.74K sold.

CoreCap Advisors first reported a position in FMS in Q1 2025 and held it in 1 quarter. The position peaked at $2.74K in Q1 2025. 207 funds tracked by Wall St. Rank hold FMS as of Q2 2025.

  • CoreCap Advisors reported no remaining Fresenius Medical Care position as of Q2 2025 after selling out during the quarter.
  • CoreCap Advisors sold 110 Fresenius Medical Care shares in Q2 2025, an estimated $2.74K.
  • CoreCap Advisors first reported a position in Fresenius Medical Care in Q1 2025 and held it in 1 quarter.
  • CoreCap Advisors's Fresenius Medical Care position peaked at $2.74K in Q1 2025.
  • 207 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2025.

Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.